Responses
Oral Presentations
Latest advances in the treatment and management of psoriatic arthritis and the latest news on the use of biosimilars in RMDs
OP0328-PARE Patient safety in relation to biosimilars – how can we act as a patient organization?
Compose a Response to This Article
Other responses
No responses have been published for this article.